MONTREAL, QUEBEC, CANADA AND CAMBRIDGE, ENGLAND--(MARKET WIRE)--Sep 19, 2007 -- ProMetic Life Sciences Inc. (Toronto:PLI.TO - News)("ProMetic") announces that its UK-based subsidiary, ProMetic BioSciences Ltd ("PBL"), in collaboration with a biomanufacturing client, has once more successfully implemented a large-scale purification bioprocess using a ProMetic Mimetic Ligand(TM) affinity adsorbent which has met all of its client's performance targets.
